Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

StageZero Life Sciences Ltd. Regulatory Filings 2020

Jun 23, 2020

44586_rns_2020-06-22_800d0704-79c9-4a72-8719-aede030fcda4.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

UNDERTAKING

Section 4.2(a)(x)(x.1) of National Instrument 44-101

  • TO: Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission (collectively, the " Securities Administrators ")

  • RE: StageZero Life Sciences Ltd. Final Short Form Prospectus dated June 22, 2020 (the “ Prospectus ”)

StageZero Life Sciences Ltd. (the " Corporation ") hereby undertakes to the Securities Administrators that it will file promptly any documents and materials required to be filed but that have not been executed at the time of filing final materials, including the Agency Agreement and Warrant Indenture, and in any event no later than seven days after the document becomes effective.

Capitalized terms not defined herein have the meanings ascribed to them in the Prospectus of the Corporation.

Dated this 22[nd] day of June 2020.

STAGEZERO LIFE SCIENCES LTD.

"James Howard-Tripp"

Per: _________________________________ James Howard-Tripp Chairman and Chief Executive Officer

14852643.4